Cite
HARVARD Citation
del Alcázar, E. et al. (2020). Real‐world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group. Journal of the European Academy of Dermatology and Venereology. pp. 2821-2829. [Online].